Development of a Multicompartment Permeability‐Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|10|605-613

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.10, 2015-10, pp. : 605-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biopharmaceutics, Pharmacokinetics and Pharmacodynamics of Antituberculosis Drugs

By  

Current Medicinal Chemistry, Vol. 15, Iss. 8, 2008-04 ,pp. : 809-825

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics and its Role in Anti-Tuberculosis Drug Development and Optimization of Treatment

By  

Current Pharmaceutical Design, Vol. 17, Iss. 27, 2011-09 ,pp. : 2889-2899

Bentham Science Publishers

Access to resources Recommend Favorite

Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transport

By Thompson Matthew  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 4, 2011-08 ,pp. : 405-421

Springer Publishing Company

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

Physiologically based pharmacokinetics (PBPK)

By Espié Pascal   Tytgat Dominique   Sargentini-Maier Maria-Laura   Poggesi Italo   Watelet Jean-Baptiste  

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 391-407

Informa Healthcare

Access to resources Recommend Favorite